Pages that link to "Q37277734"
Jump to navigation
Jump to search
The following pages link to Association of the metabolic syndrome with pulmonary venous hypertension (Q37277734):
Displaying 50 items.
- Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and management (Q26750994) (← links)
- Under pressure: pulmonary hypertension associated with left heart disease (Q26775852) (← links)
- Metabolic Syndrome and the Lung (Q28384152) (← links)
- Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction (Q33788474) (← links)
- Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? (Q33790168) (← links)
- Causes of pulmonary hypertension in the elderly (Q33829641) (← links)
- Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies (Q33849207) (← links)
- Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease. (Q33965866) (← links)
- Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension (Q34118474) (← links)
- Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1 (Q34178976) (← links)
- Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man (Q34245617) (← links)
- Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report (Q34535086) (← links)
- International Classification of Diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: implications for database studies (Q34617437) (← links)
- Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factors (Q34782595) (← links)
- Pulmonary hypertension in women (Q34795939) (← links)
- An official American Thoracic Society Statement: pulmonary hypertension phenotypes (Q34919733) (← links)
- Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertension (Q35016971) (← links)
- Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension. (Q35019516) (← links)
- Pulmonary arterial dysfunction in insulin resistant obese Zucker rats (Q35035330) (← links)
- Unrecognized glucose intolerance is common in pulmonary arterial hypertension (Q35085796) (← links)
- Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome. (Q35354138) (← links)
- Impact of diabetes in patients with pulmonary hypertension (Q35517404) (← links)
- Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers (Q35665777) (← links)
- End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment (Q36411378) (← links)
- SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction (Q36614556) (← links)
- Pulmonary Arterial Pressure Response During Exercise in COPD: A Correlation with C-Reactive Protein (hsCRP). (Q36676088) (← links)
- Metabolic Dysfunction in Pulmonary Arterial Hypertension (Q36825335) (← links)
- Pulmonary hypertension in Saudi Arabia: A single center experience (Q36886438) (← links)
- WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension (Q37073847) (← links)
- A potential role for insulin resistance in experimental pulmonary hypertension (Q37104263) (← links)
- The emerging epidemic of heart failure with preserved ejection fraction (Q37407880) (← links)
- Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity (Q37591231) (← links)
- High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension (Q37602928) (← links)
- Rodent models of pulmonary hypertension: harmonisation with the world health organisation’s categorisation of human PH (Q37898745) (← links)
- Update on Pulmonary Vascular Diseases 2010 (Q37898899) (← links)
- Experimental and transgenic models of pulmonary hypertension. (Q38112056) (← links)
- Management of pulmonary hypertension due to heart failure with preserved ejection fraction (Q38260650) (← links)
- Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes (Q38703008) (← links)
- Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease. (Q38737284) (← links)
- Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (Q39042753) (← links)
- Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension. (Q39118942) (← links)
- Echocardiographic Pulmonary Artery Systolic Pressure in the Coronary Artery Risk Development in Young Adults (CARDIA) Study: Associations With Race and Metabolic Dysregulation. (Q41166063) (← links)
- Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension (Q46336560) (← links)
- Determinants of resource utilization and outcomes in laparoscopic Roux-en-Y gastric bypass: a multicenter analysis of 14,251 patients (Q46859800) (← links)
- Cell death-inducing DFF45-like effector C gene silencing alleviates pulmonary vascular remodeling in a type 2 diabetic rat model. (Q47594967) (← links)
- Comparative effectiveness of sildenafil for pulmonary hypertension due to left heart disease with HFrEF. (Q48004922) (← links)
- Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction (Q50935737) (← links)
- Pulmonary Arterial Hypertension and Insulin Resistance. (Q54946092) (← links)
- Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease. (Q55287581) (← links)
- Clinical and hemodynamic factors in predicting response to fluid challenge during right heart catheterization (Q60948893) (← links)